BamSEC and AlphaSense Join Forces
Learn More

Talphera Inc.

NASDAQ: TLPH    
Share price (1/7/25): $0.64    
Market cap (1/7/25): $10.9 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 4 pages Talphera, Inc. Amendment No. 1 to Securities Purchase Agreement
12/34/56
EX-10.2
from 8-K 13 pages Talphera, Inc. Amended and Restated 2011 Employee Stock Purchase Plan
12/34/56
EX-10.1
from 8-K 36 pages Talphera, Inc. Amended and Restated 2020 Equity Incentive Plan
12/34/56
EX-10.1
from 10-Q 57 pages Certain Identified Information Has Been Excluded (Indicated By: [***]) From the Exhibit Because It Is Both (I) Not Material and (II) the Type of Information That the Registrant Customarily and Actually Treats as Private or Confidential. Payment Interest Purchase Agreement by and Between Talphera, Inc. and Xoma (US) LLC Dated as of January 12, 2024
12/34/56
EX-10.4
from 8-K 14 pages Prefunded Common Stock Purchase Warrant Talphera, Inc
12/34/56
EX-10.3
from 8-K 23 pages Talphera, Inc. Registration Rights Agreement
12/34/56
EX-10.2
from 8-K 29 pages Talphera, Inc. Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 31 pages Talphera, Inc. Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 36 pages Acelrx Pharmaceuticals, Inc. Amended and Restated 2020 Equity Incentive Plan
12/34/56
EX-10.7
from 8-K 18 pages Placement Agent Series B Common Stock Purchase Warrant Acelrx Pharmaceuticals, Inc
12/34/56
EX-10.6
from 8-K 18 pages Placement Agent Series a Common Stock Purchase Warrant Acelrx Pharmaceuticals, Inc
12/34/56
EX-10.5
from 8-K 18 pages Prefunded Common Stock Purchase Warrant Acelrx Pharmaceuticals, Inc
12/34/56
EX-10.4
from 8-K 19 pages Series B Common Stock Purchase Warrant Acelrx Pharmaceuticals, Inc
12/34/56
EX-10.3
from 8-K 17 pages Series a Common Stock Purchase Warrant Acelrx Pharmaceuticals, Inc
12/34/56
EX-10.2
from 8-K 22 pages Acelrx Pharmceuticals, Inc. Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 30 pages Acelrx Pharmaceuticals, Inc. Securities Purchase Agreement
12/34/56
EX-10.23
from 10-K/A 6 pages Amendment #1 to Manufacturing Services Agreement Between Patheon Pharmaceuticals, Inc. and Acelrx Pharmaceuticals, Inc
12/34/56
EX-10.21
from 10-K/A 12 pages Amended and Restated Capital Expenditure and Equipment Agreement
12/34/56
EX-10.20
from 10-K/A 52 pages [*] = Certain Confidential Information Contained in This Document, Marked by Brackets, Has Been Omitted Because It Is Both (I) Not Material and (II) Is of the Type That Would Likely Cause Competitive Harm if Publicly Disclosed
12/34/56
EX-10.1
from 8-K 36 pages Securities Purchase Agreement
12/34/56